We are live on ! Find out more
Lord, Abbett & Co

Lord, Abbett & Co Portfolio holdings

AUM $30.6B
1-Year Est. Return 57.44%
This Fund
S&P 500
This Quarter Est. Return
+5.86%
1 Year Est. Return
+57.44%
3 Year Est. Return
+215.76%
5 Year Est. Return
+368.6%
10 Year Est. Return
+2,376.62%
AUM
$39.5B
AUM Growth
+$59.4M
Cap. Flow
-$2.29B
Cap. Flow %
-5.81%
Top 10 Hldgs %
11.01%
Holding
1,026
New
121
Increased
328
Reduced
359
Closed
133

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$338M
2
UNH icon
UnitedHealth
UNH
+$140M
3
XOM icon
ExxonMobil
XOM
+$134M
4
ATVI
Activision Blizzard
ATVI
+$122M
5
VZ icon
Verizon
VZ
+$118M

Sector Composition

Rank Sector Weight
1 Financials 15.07%
2 Healthcare 14.16%
3 Technology 13.06%
4 Industrials 12.52%
5 Consumer Discretionary 10.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RGLD icon
801
Royal Gold
RGLD
$16.5B
$1.77M ﹤0.01%
+28,000
New +$1.92M
RMAX icon
802
RE/MAX Holdings
RMAX
$207M
$1.75M ﹤0.01%
+52,700
New +$1.8M
CSX icon
803
CSX Corp
CSX
$94B
$1.74M ﹤0.01%
157,233
+29,067
+23% +$334K
FOXF icon
804
Fox Factory Holding Corp
FOXF
$805M
$1.74M ﹤0.01%
113,100
-39,200
-26% -$605K
RRTS
805
DELISTED
RoadRunner Transportation Systems, Inc.
RRTS
$1.72M ﹤0.01%
2,724
WHG icon
806
Westwood Holdings Group
WHG
$187M
$1.71M ﹤0.01%
28,400
-14,700
-34% -$893K
PGNX
807
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$1.71M ﹤0.01%
286,361
-254,172
-47% -$1.6M
EPZM
808
DELISTED
Epizyme, Inc
EPZM
$1.64M ﹤0.01%
87,134
-23,980
-22% -$495K
GRFS
809
Grifois
GRFS
$5.59B
$1.64M ﹤0.01%
99,636
-39,728
-29% -$665K
AZZ icon
810
AZZ Inc
AZZ
$4.34B
$1.59M ﹤0.01%
34,100
FARM
811
DELISTED
Farmer Brothers
FARM
$1.54M ﹤0.01%
62,100
-13,700
-18% -$365K
TOWR
812
DELISTED
Tower International, Inc.
TOWR
$1.52M ﹤0.01%
57,100
SIMO icon
813
Silicon Motion
SIMO
$7.67B
$1.49M ﹤0.01%
+55,500
New +$1.52M
GSK icon
814
GSK
GSK
$106B
$1.47M ﹤0.01%
25,538
+786
+3% +$45.1K
HNGR
815
DELISTED
Hanger Inc.
HNGR
$1.47M ﹤0.01%
+64,800
New +$1.52M
BABA icon
816
Alibaba
BABA
$275B
$1.42M ﹤0.01%
17,000
-111,396
-87% -$10.1M
RALY
817
DELISTED
RALLY SOFTWARE DEV CORP
RALY
$1.29M ﹤0.01%
+82,549
New +$1.01M
GMCR
818
DELISTED
KEURIG GREEN MTN INC
GMCR
$1.29M ﹤0.01%
11,524
-150,994
-93% -$18.9M
SAMG icon
819
Silvercrest Asset Management
SAMG
$80.6M
$1.28M ﹤0.01%
90,100
-376,035
-81% -$5.35M
EGBN icon
820
Eagle Bancorp
EGBN
$868M
$1.28M ﹤0.01%
33,400
SNY icon
821
Sanofi
SNY
$109B
$1.17M ﹤0.01%
23,744
-5,485
-19% -$262K
BP icon
822
BP
BP
$111B
$959K ﹤0.01%
29,546
+6,419
+28% +$210K
ORCL icon
823
Oracle
ORCL
$343B
$680K ﹤0.01%
15,765
+827
+6% +$35.8K
SHAK icon
824
Shake Shack
SHAK
$2.55B
$584K ﹤0.01%
+11,668
New +$524K
DCUB
825
DELISTED
DOMINION RESOURCES INC CORP UNIT 2013 SER B (VA)
DCUB
$564K ﹤0.01%
10,000
-50,000
-83% -$2.95M

Similar funds

Lord, Abbett & Co's Q1 2015 Portfolio in Review

As of Q1 2015, Lord, Abbett & Co held 1,026 positions worth $39.5B, up 0.15% from $39.4B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Lord, Abbett & Co withdrew a net $2.29B in Q1 2015, closing 133 positions and reducing 359 holdings. Its most notable exit was POLYPORE INTERNATIONAL, INC, an estimated $85M position sold in full.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Lord, Abbett & Co opened a new position in ACTAVIS PLC Pfd Conv Ser A (Irl) worth $76.9M.

  • Lord, Abbett & Co's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 75,968 shares worth $76.9M.
  • Lord, Abbett & Co added most to Pfizer in Q1 2015, an estimated $338M increase.
  • Lord, Abbett & Co's biggest Q1 2015 reduction was Bristol-Myers Squibb, cutting an estimated $274M.
  • Lord, Abbett & Co fully exited POLYPORE INTERNATIONAL, INC in Q1 2015, selling an estimated $85M.
  • Lord, Abbett & Co's ten largest holdings make up 11% of its $39.5B portfolio in Q1 2015.
  • Lord, Abbett & Co opened 121 new positions and closed 133 in Q1 2015.
  • Lord, Abbett & Co's portfolio value rose 0.15% quarter-over-quarter to $39.5B.

Based on Lord, Abbett & Co's 13F filing for Q1 2015, filed 15 May 2015.